These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37301731)

  • 1. The health care and societal costs of inherited retinal diseases in Australia: a microsimulation modelling study.
    Schofield D; Kraindler J; Tan O; Shrestha RN; West S; Hart N; Tan L; Ma A; Grigg JR; Jamieson RV
    Med J Aust; 2023 Jul; 219(2):70-76. PubMed ID: 37301731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-of-illness studies of inherited retinal diseases: a systematic review.
    Ng QX; Ong C; Yaow CYL; Chan HW; Thumboo J; Wang Y; Koh GCH
    Orphanet J Rare Dis; 2024 Feb; 19(1):93. PubMed ID: 38424595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic impact of informal caring for a person with arthritis in Australia from 2015 to 2030: a microsimulation approach using national survey data.
    Schofield DJ; Lim K; Tanton R; Veerman L; Kelly SJ; Passey M; Shrestha R
    BMJ Open; 2024 May; 14(5):e076966. PubMed ID: 38719327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Inherited Retinal Diseases in the United States of America (US) and Canada from a Cost-of-Illness Perspective.
    Gong J; Cheung S; Fasso-Opie A; Galvin O; Moniz LS; Earle D; Durham T; Menzo J; Li N; Duffy S; Dolgin J; Shearman MS; Fiorani C; Banhazi J; Daly A
    Clin Ophthalmol; 2021; 15():2855-2866. PubMed ID: 34234408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term economic impacts of arthritis through lost productive life years: results from an Australian microsimulation model.
    Schofield D; Cunich M; Shrestha RN; Tanton R; Veerman L; Kelly S; Passey ME
    BMC Public Health; 2018 May; 18(1):654. PubMed ID: 29793478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifetime Costs of Hospitalised Cardiovascular Disease in Australia: An Incidence-Based Estimate.
    Nghiem S; Afoakwah C; Byrnes J; Scuffham P
    Heart Lung Circ; 2021 Aug; 30(8):1207-1212. PubMed ID: 33632592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs of diabetes among Australians aged 45-64 years from 2015 to 2030: projections of lost productive life years (PLYs), lost personal income, lost taxation revenue, extra welfare payments and lost gross domestic product from Health&WealthMOD2030.
    Schofield D; Shrestha RN; Cunich MM; Passey ME; Veerman L; Tanton R; Kelly SJ
    BMJ Open; 2017 Jan; 7(1):e013158. PubMed ID: 28069621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Inherited Retinal Diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a Cost-of-Illness Perspective.
    Galvin O; Chi G; Brady L; Hippert C; Del Valle Rubido M; Daly A; Michaelides M
    Clin Ophthalmol; 2020; 14():707-719. PubMed ID: 32184557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The personal and national costs of early retirement because of spinal disorders: impacts on income, taxes, and government support payments.
    Schofield DJ; Shrestha RN; Percival R; Passey ME; Callander EJ; Kelly SJ
    Spine J; 2012 Dec; 12(12):1111-8. PubMed ID: 23092718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The personal and national costs of mental health conditions: impacts on income, taxes, government support payments due to lost labour force participation.
    Schofield DJ; Shrestha RN; Percival R; Passey ME; Callander EJ; Kelly SJ
    BMC Psychiatry; 2011 Apr; 11():72. PubMed ID: 21526993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual disability and autism: socioeconomic impacts of informal caring, projected to 2030.
    Schofield D; Zeppel MJB; Tanton R; Veerman JL; Kelly SJ; Passey ME; Shrestha RN
    Br J Psychiatry; 2019 Nov; 215(5):654-660. PubMed ID: 31524109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic impact of diabetes through lost labour force participation on individuals and government: evidence from a microsimulation model.
    Schofield D; Cunich MM; Shrestha RN; Passey ME; Veerman L; Callander EJ; Kelly SJ; Tanton R
    BMC Public Health; 2014 Mar; 14():220. PubMed ID: 24592931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The personal and national costs of CVD: impacts on income, taxes, government support payments and GDP due to lost labour force participation.
    Schofield D; Shrestha R; Percival R; Passey M; Callander E; Kelly S
    Int J Cardiol; 2013 Jun; 166(1):68-71. PubMed ID: 22018513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic costs of informal care for people with chronic diseases in the community: Lost income, extra welfare payments, and reduced taxes in Australia in 2015-2030.
    Schofield D; Shrestha RN; Zeppel MJB; Cunich MM; Tanton R; Veerman JL; Kelly SJ; Passey ME
    Health Soc Care Community; 2019 Mar; 27(2):493-501. PubMed ID: 30378213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual and national financial impacts of informal caring for people with mental illness in Australia, projected to 2030.
    Schofield D; Zeppel MJB; Tanton R; Veerman JL; Kelly SJ; Passey ME; Shrestha RN
    BJPsych Open; 2022 Jul; 8(4):e136. PubMed ID: 35848155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of high prevalence mental disorders: Findings from the 2007 Australian National Survey of Mental Health and Wellbeing.
    Lee YC; Chatterton ML; Magnus A; Mohebbi M; Le LK; Mihalopoulos C
    Aust N Z J Psychiatry; 2017 Dec; 51(12):1198-1211. PubMed ID: 28565923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informal caring for back pain: overlooked costs of back pain and projections to 2030.
    Schofield D; Zeppel MJB; Tanton R; Veerman J; Kelly S; Passey ME; Shrestha RN
    Pain; 2020 May; 161(5):1012-1018. PubMed ID: 31895264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030: results from a microsimulation model.
    Schofield D; Cunich M; Shrestha R; Passey M; Veerman L; Tanton R; Kelly S
    BMC Public Health; 2019 Jun; 19(1):802. PubMed ID: 31226965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.